Detalhe da pesquisa
1.
Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model.
Am J Physiol Renal Physiol
; 315(4): F824-F833, 2018 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29167170
2.
Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
Kidney Int
; 92(3): 634-645, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28396122
3.
Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease.
Nat Commun
; 10(1): 1835, 2019 04 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31015435
4.
Simultaneous quantitative analysis of uremic toxins by LC-MS/MS with a reversed-phase/cation-exchange/anion-exchange tri-modal mixed-mode column.
J Chromatogr B Analyt Technol Biomed Life Sci
; 1068-1069: 1-8, 2017 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29024911
5.
A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-α and TGF-ß1 pathways.
Sci Rep
; 7(1): 1884, 2017 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28507324